Advanced search×

Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus

Vladimir Riazanski, Ludmila V Deriy, Pavel D Shevchenko, Brandy Le, Erwin A Gomez, and Deborah J Nelson

Nat Neurosci 14(4):487-494 (2011)

DOI: 10.1038/nn.2775
Version: za2963e q8zaa q8zb4 q8zca q8zda q8ze4 q8zfd q8zgc

Similar articles you may find interesting…

  1. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale...
    Didier Koumavi DK Ekouevi, Ramata R Touré, ...

    Pediatrics 118(4):e1071-7 (2006) PMID 16950945 PMCID 2121306

    Increased lactate levels were identified equally in infants whose mother received short-term nucleoside analogs or nevirapine single dose for prevention of mother-to-child transmission of HIV. Although not rare, hyperlactatemia was not related to short-term exposure to nucleoside analog antiretrovir...
    View PDF
  2. Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count.
    H H Knobel, A A Guelar, ... A A González

    HIV Med 9(1):14-8 (2008) PMID 18199168

    A total of 142 patients were included in the study, 61 in the H group and 81 in the L group. Skin rash developed in 6.56% of patients [95% confidence interval (CI) 2.67-15.70%] in the H group and in 14.81% of patients (95% CI 8.72-24.17%) in the L group (P=0.18). Hepatotoxicity developed in 4.92% (9...
  3. Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.
    Monidarin M Chou, Julie J Bertrand, ... Anne-Marie AM Taburet

    Antimicrob Agents Chemother 54(10):4432-9 (2010) PMID 20696882

    The aims of this open-label, single-center, multiple-dose pharmacokinetic study were to characterize nevirapine pharmacokinetics in a Cambodian population of HIV-infected patients and to identify environmental and genetic factors of variability focusing on the CYP2B6, CYP3A5 and ABCB...
    View PDF